Non-dipping blood pressure in CKD

Design

Systematic review and meta-analysis of 63 mostly retrospective studies

Population

54,515 people (33,825 with CKD) with ambulatory BP monitoring

Primary outcome

Non-dipping prevalence and associated outcomes

Effect

Prevalence 53%; dippers vs non-dippers mortality RR 0.60 (0.49–0.72)

A meta-analysis in the Journal of the American Heart Association (29 September) pooled 63 studies of ambulatory blood pressure in 54,515 people, 33,825 with CKD.

About 53% of people with CKD were non-dippers, failing to lower blood pressure by 10% at night; those without CKD were about 30% less likely to be non-dippers. Among people with CKD, dippers had lower mortality (risk ratio 0.60), fewer cardiovascular events (0.63) and slower CKD progression (0.64) than non-dippers.

Nearly all studies were retrospective and heterogeneity was high, so non-dipping is a risk marker rather than a proven target. It supports ambulatory monitoring in CKD, where clinic readings miss night-time hypertension.

• About half of people with CKD are non-dippers
• Non-dipping was associated with higher mortality and faster progression
• Use ambulatory monitoring where available to detect night-time hypertension
• Evidence for timing antihypertensives to restore dipping is not established here

Why it matters

Clinic blood pressure misses a pattern present in half of CKD patients that tracks with worse outcomes.

Don't overread it

Observational and heterogeneous — it does not show that correcting non-dipping improves outcomes.

The statistics, in plain English

A mortality RR of 0.60 (95% CI 0.49 to 0.72) for dippers is a strong association, but retrospective cohorts cannot separate dipping status from the illness severity that often causes it.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.